Home › Sjogren's Syndrome › Arizona › Tucson
Sjogren's Syndrome clinical trials in Tucson, AZ
3 studies for Sjogren's Syndrome are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Arizona Arthritis & Rheumatology Associates, P.C., Tucson
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Tucson, Tucson
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- Arizona Arthritis and Rheumatology Associates - Tucson - 2001 W Orange Grove Rd, Tucson
About Sjogren's Syndrome
Sjogren's Syndrome is an autoimmune disease that causes dryness of the mouth, eyes and other parts of the body. Learn how to relieve the symptoms.
More about Sjogren's Syndrome on MedlinePlus
Sjogren's Syndrome trials in other cities
- Houston, TX6 studies
- Boston, MA5 studies
- Washington, DC5 studies
- Arlington, TX4 studies
- Tampa, FL4 studies
- Charlotte, NC4 studies
- Cicero, IL4 studies
- Warren, MI3 studies
- Kansas City, MO3 studies
- Cypress, TX3 studies
- Clearwater, FL3 studies
- Orlando, FL3 studies
Other studies in Tucson
- Breast Cancer20 studies
- Obesity18 studies
- Non-Small Cell Lung Cancer17 studies
- Overweight15 studies
- Metastatic Cancer14 studies
- Cancer (all types)12 studies
- Cardiovascular Disease12 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Type 2 Diabetes11 studies
- Steatotic Liver Disease10 studies
- Heart Failure10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.